102 related articles for article (PubMed ID: 1792182)
1. Further studies on the musculo-fibrous anomaly of the Barrett's mucosa in esophageal carcinomas.
Rubio CA; Aberg B
Pathol Res Pract; 1991 Dec; 187(8):1009-13. PubMed ID: 1792182
[TBL] [Abstract][Full Text] [Related]
2. Musculo-fibrous anomaly in Barrett's mucosa with dysplasia.
Rubio CA; Riddell R
Am J Surg Pathol; 1988 Nov; 12(11):885-9. PubMed ID: 3189695
[TBL] [Abstract][Full Text] [Related]
3. Muscularis mucosae duplication and the musculo-fibrous anomaly in endoscopic mucosal resections for barrett esophagus: implications for staging of adenocarcinoma.
Lewis JT; Wang KK; Abraham SC
Am J Surg Pathol; 2008 Apr; 32(4):566-71. PubMed ID: 18300796
[TBL] [Abstract][Full Text] [Related]
4. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
[TBL] [Abstract][Full Text] [Related]
5. The pattern of invasion of early carcinomas in Barrett's esophagus is dependent on the depth of infiltration.
Stolte M; Kirtil T; Oellig F; Vogel C; Mueller H; May A; Ell C; Wittenberg R
Pathol Res Pract; 2010 May; 206(5):300-4. PubMed ID: 20188488
[TBL] [Abstract][Full Text] [Related]
6. Barrett's esophagus: metaplastic cells with loss of heterozygosity at the APC gene locus are clonal precursors to invasive adenocarcinoma.
Zhuang Z; Vortmeyer AO; Mark EJ; Odze R; Emmert-Buck MR; Merino MJ; Moon H; Liotta LA; Duray PH
Cancer Res; 1996 May; 56(9):1961-4. PubMed ID: 8616831
[TBL] [Abstract][Full Text] [Related]
7. Esophageal squamous carcinoma in five patients with Barrett's esophagus.
Paraf F; Fléjou JF; Potet F; Molas G; Fékété F
Am J Gastroenterol; 1992 Jun; 87(6):746-50. PubMed ID: 1590313
[TBL] [Abstract][Full Text] [Related]
8. Adequacy of esophageal squamous mucosa specimens obtained during endoscopy: are standard biopsies sufficient for postablation surveillance in Barrett's esophagus?
Gupta N; Mathur SC; Dumot JA; Singh V; Gaddam S; Wani SB; Bansal A; Rastogi A; Goldblum JR; Sharma P
Gastrointest Endosc; 2012 Jan; 75(1):11-8. PubMed ID: 21907985
[TBL] [Abstract][Full Text] [Related]
9. Double muscularis mucosae in Barrett's esophagus.
Takubo K; Sasajima K; Yamashita K; Tanaka Y; Fujita K
Hum Pathol; 1991 Nov; 22(11):1158-61. PubMed ID: 1743701
[TBL] [Abstract][Full Text] [Related]
10. Pathologists are able to differentiate reliably the lamina propria associated with Barrett's musculofibrous anomaly from submucosa in oesophageal endoscopic resections.
Kaye PV; O'Donovan M; Mapstone N; Disep B; Novelli M; Ragunath K
Histopathology; 2015 Dec; 67(6):914-7. PubMed ID: 25967252
[TBL] [Abstract][Full Text] [Related]
11. [Endoscopic diagnosis of Barrett's adenocarcinoma].
Yoshio H; Takashi Y; Mitsuyo H; Nobuhiko Y; Tatsurou T; Kazuhiko S; Yoko H; Shigemasa I; Hisanaga M; Osamu H; Katsuyoshi S; Seishi U; Matsushita H; Masahiko T
Nihon Geka Gakkai Zasshi; 1999 Mar; 100(3):244-8. PubMed ID: 10379534
[TBL] [Abstract][Full Text] [Related]
12. The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus.
Hamilton SR; Smith RR
Am J Clin Pathol; 1987 Mar; 87(3):301-12. PubMed ID: 3825997
[TBL] [Abstract][Full Text] [Related]
13. Molecular genetic analysis of surveillance biopsy samples from Barrett's mucosa--significance of sampling.
Werther M; Saure C; Pahl R; Schorr F; Rüschoff J; Alles JU; Heinmöller E
Pathol Res Pract; 2008; 204(5):285-94. PubMed ID: 18337019
[TBL] [Abstract][Full Text] [Related]
14. Expression of beta-catenin, alpha-catenin, and E-cadherin in Barrett's esophagus and esophageal adenocarcinomas.
Washington K; Chiappori A; Hamilton K; Shyr Y; Blanke C; Johnson D; Sawyers J; Beauchamp D
Mod Pathol; 1998 Sep; 11(9):805-13. PubMed ID: 9758359
[TBL] [Abstract][Full Text] [Related]
15. Expression of CD44v5 and -v6 in Barrett's carcinoma is not increased compared to that in nondysplastic Barrett's mucosa.
Menges M; Goebel R; Pueschel W; Zeitz M; Stallmach A
Exp Mol Pathol; 2002 Jun; 72(3):207-12. PubMed ID: 12009784
[TBL] [Abstract][Full Text] [Related]
16. Survivin, a potential biomarker in the development of Barrett's adenocarcinoma.
Vallböhmer D; Peters JH; Oh D; Kuramochi H; Shimizu D; Demeester SR; Hagen JA; Chandrasoma PT; Danenberg KD; DeMeester TR; Danenberg P
Surgery; 2005 Oct; 138(4):701-6; discussion 706-7. PubMed ID: 16269299
[TBL] [Abstract][Full Text] [Related]
17. Aurora kinase A in Barrett's carcinogenesis.
Rugge M; Fassan M; Zaninotto G; Pizzi M; Giacomelli L; Battaglia G; Rizzetto C; Parente P; Ancona E
Hum Pathol; 2010 Oct; 41(10):1380-6. PubMed ID: 20656315
[TBL] [Abstract][Full Text] [Related]
18. [Barrett's esophageal adenocarcinoma].
Nakamura T
Gan To Kagaku Ryoho; 2004 Mar; 31(3):322-6. PubMed ID: 15045933
[TBL] [Abstract][Full Text] [Related]
19. [Biopsy methods and pathology of Barrett's esophagus].
Takubo K; Honma N; Sawabe M; Arai T; Tanaka Y; Kino K; Iwakiri K
Nihon Rinsho; 2005 Aug; 63(8):1429-33. PubMed ID: 16101234
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of early neoplasia in Barrett's mucosa based on changes in surface structure. Comparative stereo-microscopic and histological investigations in 600 endoscopically resected specimens.
Dostler I; Ell C; Neuhaus H; Stolte M
Z Gastroenterol; 2010 May; 48(5):542-5. PubMed ID: 20449786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
